Serum endoglin levels in patients suffering from systemic sclerosis and elevated systolic pulmonary arterial pressure

International Journal of Rheumatology

Volumn 2010, Issue , 2010, Pages

  Coral Alvarado, Paola Ximena ^a,b   Garces, Maria Fernanda ^b   Caminos, Jorge Eduardo ^b   Iglesias Gamarra, Antonio ^b   Restrepo, José Félix ^b   Quintana, Gerardo ^a,b  

^a UNIVERSIDAD DE LOS ANDES   (Colombia)

^b UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CENTROMERE ANTIBODY; ENDOGLIN;

ADULT; ARTICLE; CALCINOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE DURATION; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROINTESTINAL SYMPTOM; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LUNG ARTERY PRESSURE; MALE; ONSET AGE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULMONARY HYPERTENSION; RAYNAUD PHENOMENON; SCORING SYSTEM; SYSTEMIC SCLEROSIS; SYSTOLIC BLOOD PRESSURE; TELANGIECTASIA;

EID: 79955101695     PISSN: 16879260     EISSN: 16879279     Source Type: Journal    
DOI: 10.1155/2010/969383     Document Type: Article

References (38)

1. LeRoy E. C., Black C., Fleischmajer R., Jablonska S., Krieg T., Medsger T. A. Jr., Wollheim F., Scleroderma (systemic sclerosis): classification, subsets and pathogenesis Journal of Rheumatology 1988 15 2 202 205 (Pubitemid 18073738)
2. Kahaleh M. B., The role of vascular endothelium in fibroblast activation and tissue fibrosis, particularly in scleroderma (systemic sclerosis) and pachydermoperiostosis (primary hypertrophic osteoarthropathy) Clinical and Experimental Rheumatology 1992 10, supplement 7 51 56
3. Kahaleh M. B., Vascular involvement in systemic sclerosis Clinical and Experimental Rheumatology 2004 22, supplement 33 S19 S23
4. Denton C. P., Abraham D. J., Transforming growth factor- and connective tissue growth factor: key cytokines in scleroderma pathogenesis Current Opinion in Rheumatology 2001 13 6 505 511 (Pubitemid 33070969)
5. Ihn H., Pathogenesis of fibrosis: role of TGF- and CTGF Current Opinion in Rheumatology 2002 14 6 681 685 (Pubitemid 35191556)
6. Leask A., Abraham D. J., Finlay D. R., Holmes A., Pennington D., Shi-Wen X., Chen Y., Venstrom K., Dou X., Ponticos M., Black C., Jackman J. K., Findell P. R., Connolly M. K., Dysregulation of transforming growth factor signaling in scleroderma: overexpression of endoglin in cutaneous scleroderma fibroblasts Arthritis and Rheumatism 2002 46 7 1857 1865 (Pubitemid 34774518)
7. Dharmapatni A. A., Smith M. D., Ahern M. J., Simpson A., Li C., Kumar S., Roberts-Thomson P. J., The TGF receptor endoglin in systemic sclerosis Asian Pacific Journal of Allergy and Immunology 2001 19 4 275 282 (Pubitemid 34436221)
8. Denton C. P., Black C. M., Pulmonary hypertension in systemic sclerosis Rheumatic Disease Clinics of North America 2003 29 2 335 349 (Pubitemid 36765124)
9. Coghlan J. G., Mukerjee D., The heart and pulmonary vasculature in scleroderma: clinical features and pathobiology Current Opinion in Rheumatology 2001 13 6 495 499 (Pubitemid 33070967)
10. Wigley F. M., Lima J. A. C., Mayes M., McLain D., Chapin J. L., Ward-Able C., The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists Arthritis and Rheumatism 2005 52 7 2125 2132 (Pubitemid 40994336)
11. Simon J., Gibbs R., Higenbottam T. W., Recommendations on the management of pulmonary hypertension in clinical practice Heart 2001 86 supplement 1 I1 I3
12. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee Arthritis and Rheum 1980 23 581 590
13. Battle R. W., Davitt M. A., Cooper S. M., Buckley L. M., Leib E. S., Beglin P. A., Tischler M. D., Prevalence of pulmonary hypertension in limited and diffuse scleroderma Chest 1996 110 6 1515 1519 (Pubitemid 26425153)
14. Mukerjee D., St George D., Coleiro B., Knight C., Denton C. P., Davar J., Black C. M., Coghlan J. G., Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach Annals of the Rheumatic Diseases 2003 62 11 1088 1093 (Pubitemid 37323574)
15. Clements P. J., Lachenbruch P. A., Seibold J. R., Zee B., Steen V. D., Brennan P., Silman A. J., Allegar N., Varga J., Massa M., Wigley F. M., Ingenito F., Weisman M., White B., Martin R. W., McCloskey D., Moreland L. W., Mayes M., Lally E. V., Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies Journal of Rheumatology 1993 20 11 1892 1896 (Pubitemid 24031593)
16. Denton C. P., Black C. M., Pulmonary hypertension in systemic sclerosis Rheumatic Disease Clinics of North America 2003 29 2 335 349 (Pubitemid 36765124)
17. Wipff J., Kahan A., Hachulla E., Sibilia J., Cabane J., Meyer O., Mouthon L., Guillevin L., Junien C., Boileau C., Allanore Y., Association between an endoglin gene polymorphism and systemic sclerosis-related pulmonary arterial hypertension Rheumatology 2007 46 4 622 625 (Pubitemid 46523307)
18. Gougos A., Letarte M., Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line Journal of Immunology 1988 141 6 1925 1933
19. Parker W. L., Goldring M. B., Philip A., Endoglin is expressed on human chondrocytes and forms a heteromeric complex with betaglycan in a ligand and type II TGF receptor independent manner Journal of Bone and Mineral Research 2003 18 2 289 302 (Pubitemid 36125921)
20. Gougos A., St Jacques S., Greaves A., O'Connell P. J., d'Apice A. J. F., Buhring H.-J., Bernabeu C., Van Mourik J. A., Letarte M., Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts International Immunology 1992 4 1 83 92
21. Lastres P., Cabanas C., Bellon T., Sanchez-Madrid F., Acevedo A., Gougos A., Letarte M., Bernabeu C., Regulated expression on human macrophages of endoglin, an Arg-Gly-Asp-containing surface antigen European Journal of Immunology 1992 22 2 393 397
22. Buhring H.-J., Muller C. A., Letarte M., Gougos A., Saalmuller A., Van Agthoven A. J., Busch F. W., Endoglin is expressed on a subpopulation of immature erythroid cells of normal human bone marrow Leukemia 1991 5 10 841 847
23. Chen C.-Z., Li M., De Graaf D., Monti S., Gttgens B., Sanchez M.-J., Lander E. S., Golub T. R., Green A. R., Lodish H. F., Identification of endoglin as a functional marker that defines long-term repopulating hematopoietic stem cells Proceedings of the National Academy of Sciences of the United States of America 2002 99 24 15468 15473 (Pubitemid 35403957)
24. Blann A. D., Wang J. M., Wilson P. B., Kumar S., Serum levels of the TGF-beta receptor are increased in atherosclerosis Atherosclerosis 1996 120 1-2 221 226 (Pubitemid 26053317)
25. Li C., Guo B., Wilson P. B., Stewart A., Byrne G., Bundred N., Kumar S., Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer International Journal of Cancer 2000 89 3 122 126 (Pubitemid 30185919)
26. Takahashi N., Kawanishi-Tabata R., Haba A., Tabata M., Haruta Y., Tsai H., Seon B. K., Association of serum endoglin with metastasis in patients with colorectal, breast, and other solid tumors, and suppressive effect of chemotherapy on the serum endoglin Clinical Cancer Research 2001 7 3 524 532 (Pubitemid 32707974)
27. Calabr L., Fonsatti E., Bellomo G., Alonci A., Colizzi F., Sigalotti L., Altomonte M., Musolino C., Maio M., Differential levels of soluble endoglin (CD105) in myeloid malignancies Journal of Cellular Physiology 2003 194 2 171 175 (Pubitemid 36043631)
28. Rulo H. F. C., Westphal J. R., Van De Kerkhof P. C. M., De Waal R. M. W., Van Vlijmen I. M. J. J., Ruiter D. J., Expression of endoglin in psoriatic involved and uninvolved skin Journal of Dermatological Science 1995 10 2 103 109
29. McAllister K. A., Grogg K. M., Johnson D. W., Gallione C. J., Baldwin M. A., Jackson C. E., Helmbold E. A., Markel D. S., McKinnon W. C., Murrell J., McCormick M. K., Pericak-Vance M. A., Heutink P., Oostra B. A., Haitjema T., Westerman C. J. J., Porteous M. E., Guttmacher A. E., Letarte M., Marchuk D. A., Endoglin, a TGF- binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1 Nature Genetics 1994 8 4 345 351
30. Fujimoto M., Hasegawa M., Hamaguchi Y., Komura K., Matsushita T., Yanaba K., Kodera M., Takehara K., Sato S., A clue for telangiectasis in systemic sclerosis: elevated serum soluble endoglin levels in patients with the limited cutaneous form of the disease Dermatology 2006 213 2 88 92 (Pubitemid 44215191)
31. Wipff J., Avouac J., Borderie D., Zerkak D., Lemarechal H., Kahan A., Boileau C., Allanore Y., Disturbed angiogenesis in systemic sclerosis: high levels of soluble endoglin Rheumatology 2008 47 7 972 975 (Pubitemid 351865917)
32. Coral-Alvarado P., Quintana G., Garces M. F., Cepeda L. A., Caminos J. E., Rondon F., Iglesias-Gamarra A., Restrepo J. F., Potential biomarkers for detecting pulmonary arterial hypertension in patients with systemic sclerosis Rheumatology International 2009 29 9 1017 1024
33. Amanzi L., Braschi F., Fiori G., Galluccio F., Miniati I., Guiducci S., Conforti M.-L., Kaloudi O., Nacci F., Sacu O., Candelieri A., Pignone A., Rasero L., Conforti D., Matucci-Cerinic M., Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions Rheumatology 2010 49 7 1374 1382
34. Cepeda E. J., Reveille J. D., Autoantibodies in systemic sclerosis and fibrosing syndromes: clinical indications and relevance Current Opinion in Rheumatology 2004 16 6 723 732 (Pubitemid 39425546)
35. Coral-Alvarado P., Rojas-Villarraga A., Latorre M. C., Mantilla R. D., Restrepo J. F., Pardo A. L., Chalem P., Rondn F., Juregui E., Rueda J. C., Caas C., Hincapie M. E., Pineda-Tamayo R., Alvarez F., Iglesias-Gamarra A., Diaz F. J., Anaya J.-M., Risk factors associated with pulmonary arterial hypertension in Colombian patients with systemic sclerosis: review of the literature Journal of Rheumatology 2008 35 2 244 250 (Pubitemid 351281145)
36. Mitri G. M., Lucas M., Fertig N., Steen V. D., Medsger T. A. Jr., A comparison between anti-TH/To- and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvement Arthritis and Rheumatism 2003 48 1 203 209 (Pubitemid 36091664)
37. Sulli A., Ghio M., Bezante G. P., Deferrari L., Craviotto C., Sebastiani V., Setti M., Barsotti A., Cutolo M., Indiveri F., Blunted coronary flow reserve in systemic sclerosis Rheumatology 2004 43 4 505 509 (Pubitemid 38489369)
38. Barst R. J., McGoon M., Torbicki A., Sitbon O., Krowka M. J., Olschewski H., Gaine S., Diagnosis and differential assessment of pulmonary arterial hypertension Journal of the American College of Cardiology 2004 43 12 40S 47S (Pubitemid 38759716)